Bo Huang
Beijing Key Laboratory Of Non Invasive Diagnosis And Immunotherapy Of Rheumatic Diseases
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Integrative Multiomics Approaches Identify Biomarkers Associated With Progression From Arthralgia to Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 20, 2025
Low-dose interleukin-2 in the treatment of refractory relapsing polychondritis.
Journal: Annals of the rheumatic diseases
Published: May 09, 2025
Mechanical signaling via β2 integrin decouples T cell proliferation and differentiation for generating stem cell-like CAR T cells.
Journal: Immunity
Published: August 09, 2024
Immune skew of follicular helper T cells and effector T cells in patients with Sjögren's syndrome.
Journal: Chinese medical journal
Published: September 11, 2023
Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity.
Journal: Cells
Published: August 01, 2022
Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model.
Journal: Frontiers in medicine
Published: March 01, 2022
Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.
Journal: Frontiers in cellular and infection microbiology
Published: August 13, 2021
Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study.
Journal: Rheumatology and therapy
Published: February 14, 2021
Hypomyopathic Dermatomyositis with Refractory Dermatitis Treated by Low-dose IL-2.
Journal: Dermatology and therapy
Published: June 01, 2020
Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis.
Journal: Journal of autoimmunity
Published: August 19, 2019
Last Updated: 09/26/2026